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SurgicalSolutions
Collaboration is Key to Treating Complex
Vascular Diseases and Conditions
Vascular medicine physicians also
manage the vascular wound care
program, an integral part of the JVC
which provides advanced vascular
wound services, such as multilayer
compression and absorbent
dressing (MCAD) therapy, outpatient
surgical debridement, application
of bioengineered skin grafts and
substitutes, and/or use of hyperbaric
oxygen therapy. Additionally, some
of the certified vascular medicine
physicians are involved in the
interpretation of vascular ultrasound
studies performed at the JVC vascular
laboratory.
Drs. Taki Galanis, Geno Merli, Walter Kraft, and Luis Eraso, comprise the vascular medicine component of the
Jefferson Vascular Center–now caring for patients in Center City, Methodist Hospital, and Northeast Philadelphia.

As one of the highest-volume vascular
practices on the East Coast, the
Jefferson Vascular Center (JVC) brings
together the physicians, surgeons
and pharmacists needed to deliver
coordinated, convenient patient care.

renovation that tripled its footprint and
brought the angioplasty center, staffed
by an interventional cardiologist, in close
proximity. JVC faculty members also
care for patients at Methodist Hospital
and in Northeast Philadelphia, serving a
total of about 1,500 patients annually.

The JVC’s integrated, multi-disciplinary
approach is extremely effective in
diagnosing, treating and monitoring
vascular diseases (diseases of blood
vessels) and thrombotic (bloodclotting) disorders – including complex
arterial and vein thrombosis, peripheral
artery disease, lymphedema, postthrombotic syndromes, chronic venous
insufficiency, varicose veins, vasculitis
and congenital vascular conditions.
Launched in 2009, the JVC is led by
Co-Directors Paul J. DiMuzio, MD,
FACS, the William M. Measey Professor
of Surgery and Director of the Division
of Vascular and Endovascular Surgery,
Geno Merli, MD, Senior Associate Chief
Medical Officer of Thomas Jefferson
University Hospital (TJUH), and Laurence
Needleman, MD, Associate Professor of
Radiology and Director of the Division
of Abdominal Imaging. Dr. Merli has
long been a nationally recognized
expert in deep vein thrombosis (DVT), a
potentially deadly blood clot in the leg.
Housed on the sixth floor of the
Gibbon Building at 11th and Chestnut
Streets, the JVC recently completed a
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As a medical specialty, vascular medicine
is relatively new. Jefferson’s Taki Galanis,
MD, received Board certification in
vascular medicine by being sponsored
and mentored into the specialty. More
recently, physicians have been able to
pursue fellowship training. One such
specialist is Luis H. Eraso, MD, who
joined Jefferson in June 2011 after
completing three years of fellowship
training at the Cardiovascular Division
of the Hospital of the University of
Pennsylvania. Dr. Eraso, who received
Jefferson’s Marjorie A. Bowman, MD,
’76 Early Career Investigator Award for
Primary Care Research for his work on
novel biomarkers of peripheral arterial
disease, emphasizes the value of an
integrated, multi-disciplinary center.
“Other programs offer treatment for
problems affecting the arterial, venous
and lymphatic circulatory systems, but
very few do so in one physical location,”
he says. “The Jefferson Vascular Center
brings together medical, surgical and
pharmacy specialists, which offers
benefits to patients and improvement
in care coordination and delivery.”

Equally important, Dr. Eraso says,
are the roles of Walter Kraft, MD,
who is board certified in both internal
medicine and clinical pharmacology,
and Lynda Thomson, PharmD, who
joins the vascular medicine physicians
in staffing the Jefferson Anticoagulation
and Thrombosis Service (JATS). JATS is
a busy inpatient and outpatient consult
service dedicated to coordinating
the transition of care as patients with
complex vascular conditions move
back into community-based primary
care. JATS also provides guidance in
the medical management of venous
thromboembolic disease in special
populations, including pregnant patients.
Working closely with Maternal-Fetal
Medicine, Jefferson’s high-risk obstetrics
team, the medical and pharmacy
staff at the JVC helps to manage
anticoagulation therapy throughout
their pregnancy.
“Our multi-disciplinary approach helps
prevent overlap in care—ensuring that
two specialties within the same system
aren’t dealing with the same disease in
different ways,” he concludes. “Here,
multiple specialists practice side by
side. We consult with each other
and collaborate in real time, which
enables us to provide a more seamless
experience and support better outcomes
for our patients.”
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“Patients with extensive acute deep vein
thrombosis (DVT) of the legs provide
an excellent example of why effective
medical-surgical collaboration is so
important.
“These patients typically benefit from
emergency catheter-directed thrombolysis, an endovascular procedure performed
by vascular surgeons. Subsequent medical
management is directed toward preventing re-thrombosis and preventing
the long-term complications of DVT. At
the Jefferson Vascular Center, vascular
medicine specialists initiate and transition
that care, as well as provide long-term
management of blood thinners and other
medical measures.
“Across vascular diseases and conditions,
Jefferson’s vascular medicine specialists
provide many outpatient services. In
addition to the excellent care they afford,
this collaboration allows the surgeons
to focus on complex surgical and
endovascular procedures.”
Paul J. DiMuzio, MD, FACS
William M. Measey Professor of Surgery
Director, Division of Vascular and
Endovascular Surgery

For more information about the JVC,
please visit Jefferson.edu/JVC
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